Hanmi Pharm’s Olita available for insurance benefits from coming 15th

The Ministry of Health and Welfare(Minister Neung-Hoo Park, MOHW) announced the ‘Drug Insurance Benefits List and Upper Limit Price Table’ had been revised and the Hanmi Pharm’s targeted therapy for non-small cell lung cancer ‘Olita Tab(generic name: olmutinib)’ would be applied to the health insurance benefit from the coming 15^th.

Olita Tab is a drug partially approved since it passed a Phase...